Validity And Reliability Of Mars-10 Questionnaire On Antipsychotic Adherence In Schizophrenia Patients
DOI:
https://doi.org/10.22219/sm.Vol20.SMUMM1.33729Abstract
Non-adherence in schizophrenia treatment is still a major problem in the successful treatment of schizophrenia. MARS-10 (Medication Adherence Report Scale-10) questionnaire is a self-reported questionnaire to measure patient’s adherence which has been implemented in some disease. However, there is still no study investigated the application of MARS-10 into schizophrenia patients in Indonesia. The purpose of this study was to determine the reliability and validity of the MARS-10 questionnaire in schizophrenia cases in Indonesia. This design of this study was a prospective, descriptive quantitative analysis approach with a cross-sectional design. Thirty schizophrenia patients from Saiful Anwar Hospital Malang, Lawang Mental Hospital, and UMM Hospital were used as research samples. Determining the validity of the questionnaire using the Pearson Product Moment correlation test, the correlation coefficient value r count is greater than the r table value, which is 0.361. In determining the reliability of the questionnaire, an analysis was carried out using the Cronbach's Alpha coefficient which showed the Cronbach's Alpha coefficient of 0.742. The results of the validity and reliability tests show that the MARS-10 questionnaire that has been translated into Indonesian is valid and reliable for measuring the level of compliance of schizophrenia patients with antipsychotic treatment in Indonesia.
Downloads
References
El Abdellati, K., De Picker, L. and Morrens, M. (2020) ‘Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis’, Frontiers in Neuroscience, 14(October). doi: 10.3389/fnins.2020.531763.
Ahmed, I. and Ishtiaq, S. (2021) ‘Reliability and validity: Importance in Medical Research’, Journal of the Pakistan Medical Association, 71(10), pp. 2401–2406. doi: 10.47391/JPMA.06-861.
Alhalaiqa, F. et al. (2016) ‘Adherence to Antipsychotic Drug Measured by an Arabic Version of Morisky Scale’, Issues in Mental Health Nursing, 37(12), pp. 975–982. doi: 10.1080/01612840.2016.1222040.
Anggriani, Y. et al. (2020) ‘The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System’, Value in Health Regional Issues, 21, pp. 1–8. doi: 10.1016/j.vhri.2019.05.005.
Aubel, T. (2021) ‘Cariprazine: Patients with treatment-resistant schizophrenia’, Neuropsychiatric Disease and Treatment, 17, pp. 2327–2332. doi: 10.2147/NDT.S315653.
Bègue, I., Kaiser, S. and Kirschner, M. (2020) ‘Pathophysiology of negative symptom dimensions of schizophrenia – Current developments and implications for treatment’, Neuroscience and Biobehavioral Reviews, 116, pp. 74–88. doi: 10.1016/j.neubiorev.2020.06.004.
Caqueo-Urízar, A. et al. (2020) ‘Adherence to antipsychotic medication and quality of life in Latin-American patients diagnosed with Schizophrenia’, Patient Preference and Adherence, 14, pp. 1595–1604. doi: 10.2147/PPA.S265312.
Carli, M. et al. (2021) ‘Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences’, Pharmaceuticals, 14(3). doi: 10.3390/ph14030238.
Chafi, Y. K. et al. (2021) ‘Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study’, PLoS ONE, 15(12 December), pp. 1–11. doi: 10.1371/journal.pone.0242352.
Correll, C. U. et al. (2022) ‘Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics’, Schizophrenia, 8(1), pp. 1–10. doi: 10.1038/s41537-021-00192-x.
Demirgöz Bal, M., Dişsiz, M. and Bayri Bingöl, F. (2021) ‘Validity and reliability of the turkish version of the covid stress scale’, Journal of Korean Academy of Nursing, 51(5), pp. 525–536. doi: 10.4040/jkan.21106.
Depkes RI. (2019). Riset Kesehatan Dasar. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.
Dickson, H. et al. (2020) ‘Academic achievement and schizophrenia: A systematic meta-analysis’, Psychological Medicine, 50(12), pp. 1949–1965. doi: 10.1017/S0033291720002354.
Erlinawati, E. and Muslimah, M. (2021) ‘Test Validity and Reliability in Learning Evaluation’, Bulletin of Community Engagement, 1(1), p. 26. doi: 10.51278/bce.v1i1.96.
Fatihah, A. A., Dinda Mitra, A. and Bhakti Natari, R. (2023) ‘Pola Penggunaan Antipsikotik di Rumah Sakit Tersier di Provinsi Jambi 2018 - 2021’, Jurnal Ilmiah Manusia Dan Kesehatan, 6(2), pp. 214–223. doi: 10.31850/makes.v6i2.2055.
Herlina Pratiwi, S., Raymondalexas Marchira, C. and Hendrartini, J. hendratini (2017) ‘Faktor-Faktor Yang Mempengaruhi Rawat Inap Ulang Pasien Skizofrenia Pada Era Jaminan Kesehatan Nasional Di Rumah Sakit Jiwa Grhasia Pemda Diy Determinant Factors of Schizophrenia Patients’ Readmission in the Era of National Health Insurance in Grhasia Men’, Jurnal Kebijakan Kesehatan Indonesia, 6(1), pp. 20–28.
Holm, M. et al. (2021) ‘Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers’, Acta Psychiatrica Scandinavica, 143(1), pp. 61–71. doi: 10.1111/acps.13254.
Kule, M. and Kaggwa, M. M. (2023) ‘Adherence to Typical Antipsychotics among Patients with Schizophrenia in Uganda: A Cross-Sectional Study’, Schizophrenia Research and Treatment, 2023. doi: 10.1155/2023/7035893.
De las Cuevas, C. and de Leon, J. (2020) ‘Self-report for measuring and predicting medication adherence: experts’ experience in predicting adherence in stable psychiatric outpatients and in pharmacokinetics’, Patient Preference and Adherence, 14, pp. 1823–1842. doi: 10.2147/PPA.S242693.
De las Cuevas, C. and Peñate, W. (2015) ‘Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting’, International Journal of Clinical and Health Psychology, 15(2), pp. 121–129. doi: 10.1016/j.ijchp.2014.11.003.
Leijala, J. et al. (2021) ‘Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders’, BMC Psychiatry, 21(1), pp. 1–11. doi: 10.1186/s12888-021-03037-0.
Li, X., Zhou, W. and Yi, Z. (2022) ‘A glimpse of gender differences in schizophrenia’, General Psychiatry, 35(4), pp. 2–4. doi: 10.1136/gpsych-2022-100823.
Lieslehto, J. et al. (2022) ‘Primary Nonadherence to Antipsychotic Treatment among Persons with Schizophrenia’, Schizophrenia Bulletin, 48(3), pp. 655–663. doi: 10.1093/schbul/sbac014.
Lin, D. et al. (2022) ‘Unemployment, homelessness, and other societal outcomes in patients with schizophrenia: a real-world retrospective cohort study of the United States Veterans Health Administration database: Societal burden of schizophrenia among US veterans’, BMC Psychiatry, 22(1), pp. 1–11. doi: 10.1186/s12888-022-04022-x.
McCutcheon, R. A., Krystal, J. H. and Howes, O. D. (2020) ‘Dopamine and glutamate in schizophrenia: biology, symptoms and treatment’, World Psychiatry, 19(1), pp. 15–33. doi: 10.1002/wps.20693.
Mebrahtu, G. et al. (2021) ‘Antihypertensive medication adherence and associated factors: A cross-sectional analysis of patients attending a national referral hospital in asmara, eritrea’, Patient Preference and Adherence, 15, pp. 2619–2632. doi: 10.2147/PPA.S319987.
Meilina, N. A., Cahaya, N. and Putra, A. M. P. (2022) ‘Analisis Trend Peresepan Golongan Antipsikotika Tipikal dan Atipikal di Tiga Puskesmas di Kota Banjarmasin Periode 2019-2021’, Jurnal Sains dan Kesehatan, 4(4), pp. 393–400. doi: 10.25026/jsk.v4i4.1269.
Mir, T. H. (2023) ‘Adherence Versus Compliance’, World Journal of Psychiatry, 4(2), p. 30. doi: 10.5498/wjp.v4.i2.30.
Mishra, R. et al. (2021) ‘Medication adherence and quality of life among type-2 diabetes mellitus patients in India’, World Journal of Diabetes, 12(10), pp. 1740–1749. doi: 10.4239/wjd.v12.i10.1740.
Perwitasari, D. A. et al. (2022) ‘Investigating the Relationship between Knowledge and Hepatotoxic Effects with Medication Adherence of TB Patients in Banyumas Regency, Indonesia’, International Journal of Clinical Practice, 2022. doi: 10.1155/2022/4044530.
Roemer, Emily J., West, Kesley L., Northrup, Jessica B., Iverson, Jana, M. C. (2016) ‘Measuring Adherence to Antipsychotic Medications for Schizophrenia: Concordance and Validity among a Community Sample in Rural China’, Physiology & behavior, 176(1), pp. 100–106. doi: 10.1016/j.schres.2018.05.014.Measuring.
Rubio, J. M. et al. (2021) ‘Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study’, Schizophrenia Bulletin, 47(6), pp. 1611–1620. doi: 10.1093/schbul/sbab063.
Strassnig, M. T. et al. (2021) ‘Real world sedentary behavior and activity levels in patients with schizophrenia and controls: An ecological momentary assessment study’, Mental Health and Physical Activity, 20, p. 100364. doi: 10.1016/J.MHPA.2020.100364.
Sugiarta, R. D., Arofiati, F. and Rosa, E. M. (2023) ‘Validity and Reliability of Research Instruments on the Effect of Motivation on Nurse Performance in Moderation with Nurse Credentials’, JMMR (Jurnal Medicoeticolegal dan Manajemen Rumah Sakit), 12(1), pp. 46–55. doi: 10.18196/jmmr.v12i1.6.
Tesli, M. et al. (2022) ‘Educational attainment and mortality in schizophrenia’, Acta Psychiatrica Scandinavica, 145(5), pp. 481–493. doi: 10.1111/acps.13407.
Tiihonen, J., Tanskanen, A. and Taipale, H. (2018) ‘20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia’, American Journal of Psychiatry, 175(8), pp. 765–773. doi: 10.1176/appi.ajp.2018.17091001.
WHO. (2022, 10 January). Schizophrenia. Accessed 15 December 2023, from: https://www.who.int/newsroom/fact-sheets/detail/schizophrenia
Yılmaz, S., Calikoglu, E. O. and Kosan, Z. (2019) ‘for an Uncommon Neurosurgical Emergency in a Developing Country’, Nigerian Journal of Clinical Practice, 22, pp. 1070–1077. doi: 10.4103/njcp.njcp.
Zhan, N. et al. (2023) ‘The genetic basis of onset age in schizophrenia: evidence and models’, Frontiers in Genetics, 14(June), pp. 1–10. doi: 10.3389/fgene.2023.1163361.
Zhao, J. et al. (2022) ‘Gender Differences in Psychiatric Symptoms and the Social Functioning of 610 Patients with Schizophrenia in Urban China: A 10-Year Follow-Up Study’, Neuropsychiatric Disease and Treatment, 18(July), pp. 1545–1551. doi: 10.2147/NDT.S373923.
Zhu, X. et al. (2023) ‘The Relationship Between Level of Education, Cognitive Function and Medication Adherence in Patients with Schizophrenia’, Neuropsychiatric Disease and Treatment, 19(November), pp. 2439–2450. doi: 10.2147/NDT.S424694.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nailis Syifa, Irsan Fahmi Almuhtarihan, Erika Zahrotul Avia Habba, Uhai’atun Nisa’ Nazliza, Jaza Faizun Nadifa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
